ATC Group: V09CA03 Technetium (99mTc) mertiatide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V09CA03 in the ATC hierarchy

Level Code Title
1 V Various
2 V09 Diagnostic radiopharmaceuticals
3 V09C Renal system
4 V09CA Technetium (99mTc) compounds
5 V09CA03 Technetium (99mTc) mertiatide

Active ingredients in V09CA03

Active Ingredient Description
Technetium ⁹⁹ᵐTc mertiatide

Technetium ⁹⁹ᵐTc mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients. It is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex.

Related product monographs

Title Information Source Document Type  
TECHNESCAN MAG3 Powder for solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old

Medicines in this ATC group

United States (US)

Finland (FI)

Hong Kong (HK)

Ireland (IE)

Poland (PL)

Singapore (SG)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.